EMA — authorised 3 April 2020
- Marketing authorisation holder: SciPharm Sarl
- Status: approved
🇪🇺 Remodulin in European Union
EMA authorised Remodulin on 3 April 2020
Marketing authorisation
Remodulin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Remodulin approved in European Union?
Yes. EMA authorised it on 3 April 2020.
Who is the marketing authorisation holder for Remodulin in European Union?
SciPharm Sarl holds the EU marketing authorisation.